These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8094550)
1. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs. Polak MJ; Drummond WH Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550 [TBL] [Abstract][Full Text] [Related]
2. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung. Polak MJ; Taylor DA Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367 [TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog. Clark KL; Hilditch A; Robertson MJ; Drew GM J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741 [TBL] [Abstract][Full Text] [Related]
4. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs. Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605 [TBL] [Abstract][Full Text] [Related]
5. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study. Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam. Christie MI; Smith GW J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731 [TBL] [Abstract][Full Text] [Related]
7. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. Grenader A; Healy DP J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038 [TBL] [Abstract][Full Text] [Related]
8. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep. Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow. Zhao RR; Wang PH; Zhang WF; Fennell WH Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371 [TBL] [Abstract][Full Text] [Related]
10. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. Hedge SS; Ricci A; Amenta F; Lokhandwala MF J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743 [TBL] [Abstract][Full Text] [Related]
11. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [TBL] [Abstract][Full Text] [Related]
12. Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs. Polak MJ; Kennedy LA; Drummond WH Life Sci; 1992; 51(17):1317-23. PubMed ID: 1357520 [TBL] [Abstract][Full Text] [Related]
13. Evidence against a role for dopamine D1 receptors in the myocardium of the pig. Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206 [TBL] [Abstract][Full Text] [Related]
14. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat? Clark KL; Robertson MJ; Drew GM J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary and systemic vascular effects of SKF-82526-J, a new specific peripheral dopamine receptor agonist, in unanesthetized neonatal lambs. Drummond WH; Williams BJ; Kelley KC Dev Pharmacol Ther; 1983; 6(1):1-8. PubMed ID: 6132785 [TBL] [Abstract][Full Text] [Related]
16. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats. Wang YX; Gellai M; Brooks DP Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429 [TBL] [Abstract][Full Text] [Related]
17. DA1 dopamine receptors in renal cortical collecting duct. Ohbu K; Felder RA Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man. Bakris GL; Weber RR; Nelson K; Elliott WJ; Kaplan E; Murphy MB Miner Electrolyte Metab; 1988; 14(6):343-6. PubMed ID: 2906737 [TBL] [Abstract][Full Text] [Related]
19. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613 [TBL] [Abstract][Full Text] [Related]
20. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat. Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]